Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Rua Gold Inc V.RUA

Alternate Symbol(s):  NZAUF

Rua Gold Inc., formerly First Uranium Resources Ltd., is a Canada-based mineral exploration company. The Company is focused on gold exploration and discovery in New Zealand’s historic gold mining districts. The Company projects include Reefton Goldfield and Glamorgan Project. The Reefton Goldfield Project is located in the Buller Province of the South Island, New Zealand. The Project includes... see more

Showcase News Releases

Showcase news

Geologica Resource Corp.
Geologica Acquires 100% of Lincoln Claims Developing District Play in Prolific Atlin Mining District
Revive Therapeutics Ltd
Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
Promino Nutritional Sciences Inc.
Promino Nutritional Sciences Inc. Begins Preclinical Trial to Demonstrate Effectiveness of Promino(TM) Patented IP for Retention of Muscle Mass in Cancer Patients Undergoing Aggressive Chemotherapy Treatment

More Showcase News Releases »